Polyclinique de Franche Comté

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi et al. · The Lancet · 2023 · 270 citations

Inflammation, Double-blind Phase 3, Week 16 +5

Stapled Hemorrhoidopexy Versus Milligan-Morgan Hemorrhoidectomy

Jean François Gravié, Paul‐Antoine Lehur, N. Huten et al. · Annals of Surgery · 2005 · 200 citations · Full text

Physical Therapy for Vulvar Vestibulitis Syndrome: A Retrospective Study

Sophie Bergeron, Claudia Brown, Marie-Josée Lord et al. · Journal of Sex & Marital Therapy · 2002 · 160 citations

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

Medicine, Metronomic Therapy, Gynecology +8

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

Thomas Walter, David Tougeron, Éric Baudin et al. · European Journal of Cancer · 2017 · 109 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +10